About this market
UK private ophthalmology provision spans cataract surgery, refractive surgery, glaucoma treatment and retinal surgery rather than vision correction alone. Across all approved UK locations, Rare.Monitor records ophthalmology provision at 3,362 locations, linked to 2,249 distinct owner records, on figures read on 20 August 2026. Optometry is held as a separate classification and is not counted in that figure.
FAQ
Frequently asked questions
Questions answered from Rare.Monitor data, figures read 20 August 2026.
How many UK locations record private ophthalmology treatment?
Rare.Monitor records ophthalmology provision at 3,362 approved UK locations. The tag is detected from what each location publishes about its own treatments, so the count records private provision rather than measuring the whole market, and it does not include NHS ophthalmology services. Source: Rare.Monitor, figures read 20 August 2026.What counts as ophthalmology provision in Rare.Monitor data?
Ophthalmology provision in Rare.Monitor covers cataract surgery, refractive surgery, glaucoma treatment, corneal surgery, retinal surgery, oculoplastic surgery, paediatric ophthalmology and related procedures, recorded from what each UK location publishes about its own treatments. Optometry is held as a separate classification and is not counted in this hub's figures. Source: Rare.Monitor.How is UK private ophthalmology structured by ownership?
Rare.Monitor links the 3,362 approved UK locations recording ophthalmology provision to 2,249 distinct owner records. Rare.Monitor counts distinct owner records rather than how many locations each owner holds, so these figures do not show how concentrated ownership is or how many providers operate from a single site. Locations approved most recently have not yet been matched to an owner record, so 2,249 counts the owners matched so far rather than every owner behind these locations. Source: Rare.Monitor, figures read 20 August 2026.What does Rare.Monitor track in the ophthalmology segment?
Rare.Monitor tracks treatment classifications, brand mentions and ownership links across more than 230,000 reportable locations in the United Kingdom and Republic of Ireland (ROI). For ophthalmology that covers which eye treatments each UK location publishes, which device and treatment brands it names, and which organisation owns it. Records are built from what each location publishes, so figures are restated on each new market read. Source: Rare.Monitor, platform figures read 4 August 2026.Does the UK ophthalmology figure include optometry?
No. Optometry is a separate Rare.Monitor classification and is not part of this hub's definition, so it is not counted in the 3,362 on this page. Ophthalmology here covers cataract surgery, refractive surgery, glaucoma treatment, corneal surgery, retinal surgery, oculoplastic surgery and paediatric ophthalmology. A wider figure combining ophthalmology and optometry appears in separate Rare market reporting and is not comparable with this page. Source: Rare.Monitor, figures read 20 August 2026.
Methodology: Rare.Monitor is a private-market dataset, built on what each location publishes about its own treatments rather than on an official market survey, so a count records provision rather than measuring the whole market. Market figures on this page were read on 20 August 2026, in one read. Rare.Monitor records ophthalmology provision at 3,362 approved UK locations, linked to 2,249 distinct owner records over the same locations in the same read. Ophthalmology here covers cataract surgery, refractive surgery, glaucoma treatment, corneal surgery, retinal surgery, oculoplastic surgery and paediatric ophthalmology. Optometry is a separate classification and is not counted here. Locations in this cohort were approved into the dataset between February and August 2026. Rare.Monitor counts distinct owner records rather than how many locations each owner holds, so they support no statement about how concentrated ownership is. Provider matching runs as a later stage, so locations approved most recently are not yet matched to an owner record, and the count covers the owners matched so far rather than every owner behind these locations. The classification is detected from website text rather than confirmed by a regulator, so a count carries some records the detection has placed wrongly. Most records have not yet had a full treatment re-scrape, so the count records the locations detected so far rather than every UK location offering these treatments. Classification passes for the cohort fall in a rolling nine to ten week window rather than on one fixed collection date. Platform-wide figures were read separately on 4 August 2026 and are not comparable with the market figures above. Figures in the linked analyses below come from earlier snapshots measured on their own bases, so they are not a trend series with the figures on this page. Source: Rare.Monitor.